CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dbv Technologies - ADR Company Snapshot
Dbv Technologies operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dbv Technologies with three other companies in this sector in UNITED STATES : Paratek Pharmaceuticals Inc (2019 sales of $16.54 million of which 100% was Novel Therapeutics), Assembly Biosciences Inc ($15.96 million ), and Chimerix Inc ($12.52 million of which 100% was Pharmaceutical).

Sales Analysis. Dbv Technologies reported sales of $14.69 million for the year ending December of 2019. This represents a decrease of 14.3% versus 2018, when the company's sales were $17.13 million.
   
   
 
  Stock Performance Chart for Dbv Technologies - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 1.95
(Figures in U.S. Dollars)
1 Week -1.5%   13 Weeks -6.3%  
4 Weeks -63.7%   52 Weeks -79.4%  
 
Dbv Technologies - ADR Key Data:
  Ticker: DBVT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 14,686,117
(Year Ending Jan 2020).
Employees: 311
  Currency: U.S. Dollars Market Cap: 214,008,935
  Fiscal Yr Ends: December Shares Outstanding: 109,748,172
  Share Type: Common Closely Held Shares: 8,642,182
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.